BANNISTER, Robin Mark,RICHARDS, Andrew John McGlashan,GILBERT, Julian Clive,MORTON, David A. V.,STANIFORTH, John
申请号：
ES01966751
公开号：
ES2266242T5
申请日:
2001.04.09
申请国别(地区):
ES
年份:
2016
代理人:
摘要：
A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
